PharmaResearch Hits Record Results on Rejuran as Q2 Growth Momentum Returns
Published: · Source: hankyung.com

PharmaResearch has again delivered record results led by Rejuran, according to an analysis cited by Korea Economic Daily. The report said the company’s earnings improvement remains centered on Rejuran, while attention is now on the possible return of growth momentum in the second quarter. Rejuran was identified as a core product driving performance, and the analysis linked the latest record results with a potential recovery trend in Q2. Investors are expected to watch how Rejuran demand affects future earnings. Source: hankyung.com
Partner picks
Relevant partner links for this story
A lightweight commerce block designed to add monetization without breaking reading flow.
This module may include affiliate links that earn a commission from qualifying purchases. 외환원자재나우


